1996
DOI: 10.1183/09031936.96.09071562
|View full text |Cite
|
Sign up to set email alerts
|

Pulmonary hypertension after transjugular intrahepatic portosystemic shunt (TIPS)

Abstract: We reported the case of a patient in whom severe, and ultimately fatal, pulmonary hypertension developed 1.5 yrs after transjugular intrahepatic portosystemic shunt (TIPS).Pulmonary artery pressures were not affected by 100% oxygen, prostacyclin or nifedipine. Postmortem examinations showed pulmonary and vascular abnormalities typical of pulmonary hypertension.Pulmonary artery pressures should be measured in each patient with otherwise not readily explained dyspnoea following transjugular intrahepatic portosys… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

1998
1998
2018
2018

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(6 citation statements)
references
References 12 publications
0
6
0
Order By: Relevance
“…The development of pulmonary hypertension is another rare shunt-induced complication described recently (79,80) and observed in 3 of our 900 patients with a TIPS. These three patients were young females with autoimmune liver disease (2 patients) or hepatitis C who already had mild clinical symptoms of pulmonary hypertension before the TIPS implantation.…”
Section: Shunt Related Complicationsmentioning
confidence: 79%
“…The development of pulmonary hypertension is another rare shunt-induced complication described recently (79,80) and observed in 3 of our 900 patients with a TIPS. These three patients were young females with autoimmune liver disease (2 patients) or hepatitis C who already had mild clinical symptoms of pulmonary hypertension before the TIPS implantation.…”
Section: Shunt Related Complicationsmentioning
confidence: 79%
“…Thus, the effects of TIPS on the pulmonary circulation depend on the dynamic interaction of the changes in venous return, effective circulating volume, systemic vascular resistance, and myocardial reserve. The varying outcomes of patients with cirrhotic pulmonary hypertension and hepatopulmonary syndrome after TIPS are due to the varying outcomes of the interactions between these variables [91,92]. Because the outcome is not predictable and may actually worsen the clinical condition, TIPS are not indicated for these conditions.…”
Section: Livermentioning
confidence: 97%
“…Such changes remained for at least 30 days post-TIPS and reflected neurohumoral effects as opposed to increased preload. A significant increase in right ventricular work was documented and the potential effect on right ventricular function could be deleterious in patients with pre-existing PPH [68].…”
Section: Other Therapiesmentioning
confidence: 99%